Aliri Bioanalysis launches 37 ready-to-use biomarker panels, increasing access to disease insights
Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context
Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses
One lab shares its experience boosting efficiency and accuracy with StatLab’s PiSmart Cassette and Slide printers
Guest editorial from Dr. Matt Westfall, Senior Director of Biochemical Pharmacology and Proteomics at Inotiv
testo Saveris 1 provides automated and efficient support in complying with regulatory requirements
Agreement with Illumina brings industry-leading sequencing platforms together with Devyser’s validated genetic testing solutions
Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development
Offering sample audit traceability, and sample tracking and data sharing between multiple users, labs and locations, tri-coded sample tubes provide a lifelong and secure chain of custody
In this guest editorial, Dr. Wubin Qu, CSO and Co-Founder of iGeneTech, offers perspective on changing NGS workflows vs changing capture kit reagents
New strategies pair high-performance chromatography with digital tools to tackle persistent pollutants
Partnership will advance scientific instrumentation and accelerate laboratory performance
Reimagining clinical microbiology with key technologies and long-acting therapies
Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti HER2, antibody trastuzimab, for treatment of breast cancer
Your guide to achieving sensitivity, specificity, and scalability with multiplexed biomarker analysis
Dr. Lauren Murphy at the University of Oxford is investigating how platelets could hold the key to detecting cancer in patients with minimal residual disease
Researchers harness next-generation detectors to capture magnetic dynamics in microseconds
See how experts at Merck are delivering trusted stains, dyes, and antibodies for confident and innovative diagnostics